Estrogen Current Events | Estrogen News | 8
|
| Page
8 of
14 |
262 Results |
|
|
|
Sort By:
Page Views | Date |
Impact of a chemical component of diesel exhaust particles
A new study finds that exposure to a chemical component of diesel exhaust particles can compromise the ability of resistance arteries to regulate blood flow to bone marrow. view more (2007-05-01)
Weight gain may increase risk of breast cancer in postmenopausal women
Weight gain, particularly after menopause, is associated with an increased risk of breast cancer in women. view more (2006-07-12)
Forsyth scientists find linkages between serotonin reuptake inhibitors and bone mass
Scientists at The Forsyth Institute have found that fluoxetine (Prozac), a drug used in the treatment of depression and obsessive-compulsive disorders, increases bone mass. view more (2006-10-13)
New Cause of Tamoxifen Resistance in Breast Cancer Cells Discovered at Lombardi
When a woman receives a breast cancer diagnosis her entire life may change in the blink of an eye. But the nature of that change is governed by the smallest alterations that take place within the proteins of the tumor cells, determining what treatments she can pursue with a hope of cure and those to which her cancer is resistant. view more (2007-08-13)
Gene expression test reveals ER and HER-2 status of breast tumors
Two critical characteristics of breast cancer that are important to treatment can be identified by measuring gene expression in the tumor, a research team led by scientists at The University of Texas M. D. Anderson Cancer Center reports in Lancet Oncology online. view more (2007-02-15)
Hormone patch may provide some increase in sexual desire in menopausal women
A testosterone patch may produce modest increases in sexual desire and frequency of satisfying sexual experiences in women who develop distressful, low sexual desire following hysterectomy and removal of the fallopian tubes and ovaries, according to a study in the July 25 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. view more (2005-07-26)
Hot flashes: Studies explore the role of genes, obesity and alcohol
Many women in the menopausal transition experience hot flashes: unpredictable, sometimes disruptive, periods of intense heat in the upper torso, neck and face. view more (2007-04-25)
HRT-breast cancer risk stays same, regardless of family history
The risk of developing breast cancer due to taking hormone replacement therapy appears to be the same for women with a family history of the disease and without a family history. view more (2009-05-20)
Postmenopause and periodontal disease
Postmenopausal women may significantly reduce tooth loss by controlling their periodontal disease, according to a study in the Journal of Periodontology. view more (2005-07-25)
Decrease in breast cancer incidence linked to drop in hormone replacement
A special report in the April 19, 2007 edition of The New England Journal of Medicine concludes that the sharp decline in breast-cancer incidence in 2003, followed by a relative stabilization at a lower rater in 2004, is most likely related to the first report of the Women's Health Initiative (WHI) and the ensuing drop in hormone-replacement... view more... (2007-04-19)
Molecular imaging holds promise for early intervention in common uterine cancer
A promising new molecular imaging technique may provide physicians and patients with a noninvasive way to learn more information about a type of cancer of the uterus lining called "endometrial carcinoma"-one of the most common malignant female tumors. view more (2009-10-01)
Harmful chemicals may reprogram gene response to estrogen
New research shows that exposure to harmful chemicals and drugs during critical developmental periods early in life may actually "reprogram" the way certain genes respond to the female hormone estrogen. This genetic reprogramming may determine whether people with a genetic predisposition for a disease actually develop the disease. view more (2005-05-31)
A new take on growth factor signaling in tamoxifen resistance
Differences in growth factor (GF) signaling may cause the poor prognosis in some breast cancer cases. A new study, published in the open access journal BMC Medical Genomics, suggests that some estrogen receptor-positive breast cancers respond poorly to tamoxifen because of increased GF signaling. view more (2009-06-24)
Smoking, eating and thinking: New research on the brain, hormones, and behavior
Certain hormones may make it more difficult for some to quit smoking. view more (2006-06-21)
Estrogen therapy could be dangerous for women with existing heart risk
Hormone therapy could accentuate certain pre-existing heart disease risk factors and a heart health evaluation should become the norm when considering estrogen replacement, new research suggests. view more (2008-11-26)
Hormone therapy boosts sexual interest but not memory, study finds
Hormone therapy in early post-menopause increases sexual interest, but does not improve memory, according to a study in the Sept. 25 issue of the journal Neurology. view more (2007-09-25)
Defeating nicotine's double role in lung cancer
A lung cancer treatment that inhibits nicotine receptors was shown to double survival time in mice, according to Italian researchers. view more (2009-06-09)
Study finds hereditary link to premenstrual depression
A specific genetic variation may be tied to an increased risk for severe premenstrual depression, scientists at the University of North Carolina at Chapel Hill and the National Institute of Mental Health have found. view more (2007-07-18)
Mayo Clinic researchers say agent provides treatment option for women with hot flashes
A pill used for nerve pain offers women relief from hot flashes, Mayo Clinic researchers report at the 45th Annual Meeting of the American Society of Clinical Oncology (ASCO). view more (2009-05-15)
Findings Point to Molecular 'Achilles Heel' for Half of Breast Cancer Tumors
Researchers at Lombardi Comprehensive Cancer Center at Georgetown University Medical Center have shown why a protein known as cyclin D1 may be the Achilles heel for breast tumors that are estrogen receptor positive (ER+) − which is the most common type of breast cancer. view more (2008-01-16)
|
|
| Page
8 of
14 |
262 Results |
|
|
|
Sort By:
Page Views | Date |
|
